AU2002215996A1 - Phenanthridine derivatives and antitumoral medicaments containing phenanthridine - Google Patents

Phenanthridine derivatives and antitumoral medicaments containing phenanthridine

Info

Publication number
AU2002215996A1
AU2002215996A1 AU2002215996A AU1599602A AU2002215996A1 AU 2002215996 A1 AU2002215996 A1 AU 2002215996A1 AU 2002215996 A AU2002215996 A AU 2002215996A AU 1599602 A AU1599602 A AU 1599602A AU 2002215996 A1 AU2002215996 A1 AU 2002215996A1
Authority
AU
Australia
Prior art keywords
phenanthridine
derivatives
antitumoral
medicaments containing
phenanthridine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215996A
Inventor
Bernd Clement
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002215996A1 publication Critical patent/AU2002215996A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to novel phenanthridine derivatives and to medicaments, which are for use in antitumoral therapy and prophylaxis and which contain these phenanthridine derivatives. It could be shown that up to now specifically substituted phenanthridine derivatives of the prior art neither have a known nor an antitumoral activity that is to be expected.
AU2002215996A 2000-11-02 2001-10-31 Phenanthridine derivatives and antitumoral medicaments containing phenanthridine Abandoned AU2002215996A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054337 2000-11-02
DE10054337A DE10054337A1 (en) 2000-11-02 2000-11-02 Phenanthridine derivatives and antitumor drugs containing phenanthridine
PCT/EP2001/012665 WO2002036607A1 (en) 2000-11-02 2001-10-31 Phenanthridine derivatives and antitumoral medicaments containing phenanthridine

Publications (1)

Publication Number Publication Date
AU2002215996A1 true AU2002215996A1 (en) 2002-05-15

Family

ID=7661922

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215996A Abandoned AU2002215996A1 (en) 2000-11-02 2001-10-31 Phenanthridine derivatives and antitumoral medicaments containing phenanthridine

Country Status (6)

Country Link
US (1) US6747038B2 (en)
EP (1) EP1334115B1 (en)
AT (1) ATE362480T1 (en)
AU (1) AU2002215996A1 (en)
DE (2) DE10054337A1 (en)
WO (1) WO2002036607A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110759963A (en) * 2018-07-25 2020-02-07 中山大学 Condensed ring compound and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538088A1 (en) * 1995-10-13 1997-04-17 Bernd Prof Dr Clement Phenanthridine derivatives and their preparation

Also Published As

Publication number Publication date
DE50112512D1 (en) 2007-06-28
US6747038B2 (en) 2004-06-08
US20040034051A1 (en) 2004-02-19
EP1334115B1 (en) 2007-05-16
DE10054337A1 (en) 2002-05-08
WO2002036607A1 (en) 2002-05-10
EP1334115A1 (en) 2003-08-13
ATE362480T1 (en) 2007-06-15

Similar Documents

Publication Publication Date Title
TW200510375A (en) New compounds
EP1259240B8 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
YU21702A (en) Substituted indoles for modulating nfkb activity
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PL352399A1 (en) Substituted benzimidazoles
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
WO2001030381A3 (en) Use of csf-1 inhibitors
MY126527A (en) Novel dihydropyrimidines
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2001266218A1 (en) Process for preparing and harvesting crystalline particles
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2838101A (en) Use of melatonin for treating androgenetic and diffuse alopecia
AU5915100A (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
MXPA04007391A (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders.
WO2002010152A3 (en) Novel indole derivatives and their use as medicaments
MXPA04001256A (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof.
IL143985A0 (en) New use of melagatran
MXPA03001455A (en) Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity.
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
MXPA05001469A (en) Use of fermented wheat germ extract as anti-inflammatory agent.
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
NZ515531A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods